Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates
Recruiting now · Not applicable
Conditions studied: Sepsis, Neonatal Mortality, Antibiotic Resistant Infection, Enteric Infections, Serious Bacterial Infection
In brief
The CLEAN (ChLorine to reduce Enteric and Antibiotic resistant infections in Neonates) cluster randomized controlled trial in western Kenya will evaluate the impact of a multi-component chlorination intervention in health care facilities on maternal and neonatal health. Intervention facilities will receive a passive chlorination technology for water supply treatment and a reliable supply of sodium hypochlorite disinfectant. Both intervention and treatment facilities will receive infection prevention and control messaging. The goal of the study is to evaluate the impact of the intervention on bacterial contamination of water supply, on staff hands, and on high-touch surfaces in maternity wards, and the following outcomes among facility-born neonates and their mothers: (1) gut carriage of bacterial pathogens associated with sepsis one week post-birth, (2) gut carriage of antibiotic resistant bacteria one week post-birth, and (3) symptoms of possible serious bacterial infection one week following birth.
Key facts
- Study ID
- NCT06824350
- Run by
- University of California, Berkeley
- People needed
- 45450
- Starts
- 2025-01-21
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2025-05-25
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
Where it is running
- Kenya Medical Research Institute — Nairobi, Kenya (enrolling)
- University of California, Berkeley — Berkeley, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.